FOR RESEARCH USE ONLY NOT FOR HUMAN OR ANIMAL CONSUMPTION
Store the vial refrigerated in the original carton b
The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight and demonstrated weight loss of 15 percent at the 5 mg dose, 19.5 percent at the 10 mg dose, and 20.9 percent at the 15 mg dose over 72 weeks
A recent study from the UNC School of Medicine found that an oral version of semaglutidesold in injectable form as Wegovy and Ozempiccan reduce the risk of cardiovascular events like heart attack and stroke by 14% in people with type 2 diabetes, atherosclerotic heart disease, or chronic kidney disease
Lifestyle interventions and medications like Tirzepatide can improve insulin sensitivity and manage T2DM
Olive oil, avocado, nuts, and fatty fish all contribute to skin health